NCT00516451View on ClinicalTrials.gov

Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Cancer
Interventions
DRUG

BMS-690514

Tablets, Oral, 100, 200, 250 or 300 mg once daily, 29 days or more

Trial Locations (1)

104-0045

Local Institution, Chuo-Ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00516451 - Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors | Biotech Hunter | Biotech Hunter